Johnson&johnson is to buy the remaining shares of the Verb that is a Surgical, to strengthen the digital operation’s portfolio

The logo of the Johnson & Johnson company, is shown on a display to celebrate the 75th anniversary of the company’s application for listing on the New York Stock Exchange (NYSE) in New York, New York, USA, 17 September, 2019. REUTERS/Brendan McDermid

(Reuters) – Johnson & Johnson said on Friday it would acquire the remaining stake of the Verb Surgical, Inc., from, for, Verily, the Alphabet, Inc. ‘ s life sciences division.

Is expanding its Ethicon unit, which makes surgical devices, J&J in 2015, it became an independent company with the name of the Verb, with a Surgical, Truly, smaller, smarter, lower-cost, robot-assisted systems, before the surgery. (

The deal is for the word Surgical is expected to close in the first half of the year 2020, J&J, said without the deal, terms and conditions.

J&J, pushed its way further into the surgical robotics space, with its $3.4-billion takeover of the Worth of Health, Inc., earlier this year. The deal also has a J&J with access to the private business of the surgical robot, the range is used in respiratory procedures and the detection of lung cancer.

The acquisition of the Worth of accelerating J&J’s entry into the digital operation, a kick-off to a strong pipeline of start button, which will take place in the next few years, johnson&johnson said on Friday.

Report by Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most popular